Wealth Advisors of Iowa’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$951K Buy
1,034
+10
+1% +$10.1K 0.29% 38
2025
Q4
$1.1M Hold
1,024
0.36% 38
2025
Q3
$781K Sell
1,024
-14
-1% -$10.4K 0.27% 42
2025
Q2
$809K Hold
1,038
0.3% 38
2025
Q1
$857K Buy
1,038
+139
+15% +$116K 0.37% 35
2024
Q4
$694K Sell
899
-113
-11% -$93.6K 0.35% 31
2024
Q3
$897K Buy
1,012
+58
+6% +$52.1K 0.46% 28
2024
Q2
$864K Buy
954
+55
+6% +$44K 0.48% 15
2024
Q1
$700K Buy
899
+1
+0.1% +$712 0.43% 25
2023
Q4
$524K Buy
898
+18
+2% +$10.5K 0.35% 28
2023
Q3
$473K Buy
880
+1
+0.1% +$515 0.33% 28
2023
Q2
$412K Buy
879
+1
+0.1% +$419 0.3% 31
2023
Q1
$302K Buy
878
+2
+0.2% +$675 0.24% 43
2022
Q4
$321K Buy
876
+1
+0.1% +$355 0.26% 44
2022
Q3
$283K Buy
+875
New +$277K 0.26% 39

Other funds holding LLY

Wealth Advisors of Iowa's LLY Position: Q1 2026 in Review

Wealth Advisors of Iowa increased its Eli Lilly (LLY) stake by 0.98% in Q1 2026, buying an estimated $10.1K and bringing the position to 1,034 shares worth $951K. The position accounts for 0.29% of the portfolio, ranked #38.

Wealth Advisors of Iowa first reported a position in LLY in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.1M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Wealth Advisors of Iowa held 1,034 shares of Eli Lilly worth $951K as of Q1 2026.
  • Wealth Advisors of Iowa bought 10 Eli Lilly shares in Q1 2026, an estimated $10.1K.
  • Eli Lilly made up 0.29% of Wealth Advisors of Iowa's portfolio in Q1 2026, its #38 holding.
  • Wealth Advisors of Iowa first reported a position in Eli Lilly in Q3 2022 and has held it in 15 quarters since.
  • Wealth Advisors of Iowa's Eli Lilly position peaked at $1.1M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wealth Advisors of Iowa's 13F filing for Q1 2026, filed 13 May 2026.